Ganapathy Sarma

Ganapathy Sarma holds a Ph.D. in Biochemistry and Biophysics from Oregon State University and a Master’s Degree in Biochemistry from TN Medical College, University of Mumbai. Ganapathy Sarma has extensive experience in the biotechnology and pharmaceutical sectors, serving in leadership roles such as Director at Exelixis, Director of Bioconjugations at Bolt Biotherapeutics, and Director at Magenta Therapeutics. Prior positions include Senior Scientist at Sutro Biopharma, Inc. and Scientist at Bristol-Myers Squibb.